FREDERICK, Md., Sept. 21 /PRNewswire/ -- Dr. David Allie and The Medical Renaissance Institute announce today the first charter commercial supporters for the inaugural “Renaissance Summit: Reinventing the Cardiothoracic & Vascular Surgeon.” This continuing medical education program is designed to be a valuable adjunct in strengthening an endovascular practice for cardiothoracic and vascular surgeons and will still be presented on Saturday, October 29, at the InterContinental Hotel in Miami, Fla., in conjunction with New Cardiovascular Horizons 2005 - the premier multidisciplinary cardiovascular conference in North America. Due to the devastating effects of Hurricane Katrina, the Summit has been relocated to Miami, Fla.
The educational grants from these commercial supporters will support the educational opportunities for physicians and residents attending the Summit.
To date, the Founding Charter Commercial Supporters are W. L. Gore & Associates and Medtronic. W. L. Gore & Associates (www.gore.com) began in 1958, when Bill and Vieve Gore set out to explore opportunities for fluorocarbon polymers, especially polytetrafluoroethylene (PTFE). Within the first twelve years, Gore had wire and cables on the moon and operations worldwide.
Medtronic (www.medtronic.com) is the world leader in medical technology providing lifelong solutions for people with chronic disease. Each year, 5 million patients benefit from Medtronic’s technology, used to treat conditions such as diabetes, heart disease, neurological disorders, and vascular illnesses.
To date, the Corporate Charter Commercial Supporters are Cordis Endovascular and Edwards Lifesciences. Cordis Corporation (www.cordis.com), a Johnson & Johnson company, is the world’s leading developer and manufacturer of breakthrough products for interventional medicine, minimally invasive computer-based imaging, and electrophysiology.
Edwards Lifesciences (www.edwards.com) is a global leader in products and technologies to treat advanced cardiovascular disease, the global leader in acute hemodynamic monitoring and the number-one heart valve company in the world.
To date, the Associate Charter Commercial Supporters are Cook Medical (www.cookmedical.com) and The Medicines Company (www.themedicinescompany.com).
More than 3,500 attended last year’s New Cardiovascular Horizons’ event, an environment of multidisciplinary endovascular education, including 125 exhibitors. It is anticipated that this year’s Renaissance Summit will attract 100-200 surgeons. Interested commercial supporters and exhibitors should contact Dr. Paul Zimnik, Medical Renaissance Institute, at 888-508-8554 or email zimnik@medical-renaissance.com. Visit the program website online at www.medical-renaissance.com
Medical Renaissance Institute
CONTACT: Paul Zimnik, D.O., President of Medical Renaissance Institute,+1-301-591-3767, or +1-888-508-8554, or zimnik@medical-renaissance.com
